(CG) Carlyle - Ratings and Ratios
PrivateEquity, RealAssets, GlobalMarkets, InvestmentFunds
CG EPS (Earnings per Share)
CG Revenue
Description: CG Carlyle
The Carlyle Group Inc. is a diversified investment firm with a broad range of investment strategies across four main segments: Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firms investments span multiple industries, including industrial, consumer, aerospace, defense, technology, and financial services, among others.
From a business perspective, Carlyles strength lies in its ability to invest across various asset classes and industries, providing a diversified revenue stream. Key Performance Indicators (KPIs) to monitor include Assets Under Management (AUM), investment performance, and fundraising success. As of the latest available data, Carlyles AUM is a key metric to track the firms growth and scale.
In terms of financial performance, Carlyles revenue is driven by management fees, performance fees, and investment income. Key metrics to evaluate include revenue growth, margin expansion, and return on equity (RoE). With a reported RoE of 18.58%, Carlyle demonstrates a strong ability to generate returns for shareholders.
To further assess Carlyles investment performance, its essential to examine the firms investment portfolio, including the types of investments made, industry allocation, and geographic distribution. Additionally, monitoring the firms fundraising activities, including the size and frequency of new funds, can provide insights into its ability to attract capital from investors.
From a valuation perspective, Carlyles stock trades at a P/E ratio of 19.90, with a forward P/E of 14.58, indicating a relatively attractive valuation compared to peers. The firms market capitalization stands at $21.7 billion, reflecting its size and market presence.
CG Stock Overview
Market Cap in USD | 23,305m |
Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2012-05-03 |
CG Stock Ratings
Growth Rating | 68.9% |
Fundamental | 57.8% |
Dividend Rating | 66.3% |
Return 12m vs S&P 500 | 40.8% |
Analyst Rating | 3.56 of 5 |
CG Dividends
Dividend Yield 12m | 2.42% |
Yield on Cost 5y | 6.44% |
Annual Growth 5y | 6.96% |
Payout Consistency | 89.9% |
Payout Ratio | 35.7% |
CG Growth Ratios
Growth Correlation 3m | 94.2% |
Growth Correlation 12m | 35.6% |
Growth Correlation 5y | 48.3% |
CAGR 5y | 34.23% |
CAGR/Max DD 3y | 0.89 |
CAGR/Mean DD 3y | 3.73 |
Sharpe Ratio 12m | 1.78 |
Alpha | 65.23 |
Beta | 0.671 |
Volatility | 35.23% |
Current Volume | 1402.2k |
Average Volume 20d | 2276.9k |
Stop Loss | 64.4 (-3.3%) |
Signal | -0.33 |
Piotroski VR‑10 (Strict, 0-10) 3.0
Net Income (1.26b TTM) > 0 and > 6% of Revenue (6% = 290.5m TTM) |
FCFTA 0.04 (>2.0%) and ΔFCFTA 2.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -91.18% (prev -106.3%; Δ 15.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.04 (>3.0%) and CFO 969.3m <= Net Income 1.26b (YES >=105%, WARN >=100%) |
Net Debt (8.97b) to EBITDA (1.85b) ratio: 4.86 <= 3.0 (WARN <= 3.5) |
Current Ratio 0.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (367.0m) change vs 12m ago 0.03% (target <= -2.0% for YES) |
Gross Margin 76.94% (prev 71.80%; Δ 5.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 20.45% (prev 9.94%; Δ 10.51pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 2.46 (EBITDA TTM 1.85b / Interest Expense TTM 688.1m) >= 6 (WARN >= 3) |
Altman Z'' -0.31
(A) -0.18 = (Total Current Assets 2.07b - Total Current Liabilities 6.49b) / Total Assets 25.07b |
(B) 0.08 = Retained Earnings (Balance) 1.95b / Total Assets 25.07b |
(C) 0.07 = EBIT TTM 1.69b / Avg Total Assets 23.68b |
(D) 0.11 = Book Value of Equity 1.95b / Total Liabilities 18.35b |
Total Rating: -0.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.75
1. Piotroski 3.0pt = -2.0 |
2. FCF Yield 1.98% = 0.99 |
3. FCF Margin 18.37% = 4.59 |
4. Debt/Equity 3.46 = -1.42 |
5. Debt/Ebitda 12.59 = -2.50 |
6. ROIC - WACC 4.18% = 5.23 |
7. RoE 21.43% = 1.79 |
8. Rev. Trend 9.22% = 0.46 |
9. Rev. CAGR 0.0% = 0.0 |
10. EPS Trend 24.45% = 0.61 |
11. EPS CAGR 0.0% = 0.0 |
What is the price of CG shares?
Over the past week, the price has changed by +3.82%, over one month by +3.17%, over three months by +42.36% and over the past year by +66.50%.
Is Carlyle a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CG is around 74.39 USD . This means that CG is currently undervalued and has a potential upside of +11.7% (Margin of Safety).
Is CG a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 10
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CG price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 68.1 | 2.2% |
Analysts Target Price | 68.1 | 2.2% |
ValueRay Target Price | 80 | 20.2% |
Last update: 2025-09-04 04:34
CG Fundamental Data Overview
CCE Cash And Equivalents = 1.74b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 18.8392
P/E Forward = 13.21
P/S = 4.2176
P/B = 3.9766
P/EG = 1.2421
Beta = 1.888
Revenue TTM = 4.84b USD
EBIT TTM = 1.69b USD
EBITDA TTM = 1.85b USD
Long Term Debt = 16.76b USD (from nonCurrentLiabilitiesTotal, last fiscal year)
Short Term Debt = 6.49b USD (from totalCurrentLiabilities, last quarter)
Debt = 23.24b USD (Calculated: Short Term 6.49b + Long Term 16.76b)
Net Debt = 8.97b USD (from netDebt column, last quarter)
Enterprise Value = 44.81b USD (23.30b + Debt 23.24b - CCE 1.74b)
Interest Coverage Ratio = 2.46 (Ebit TTM 1.69b / Interest Expense TTM 688.1m)
FCF Yield = 1.98% (FCF TTM 889.3m / Enterprise Value 44.81b)
FCF Margin = 18.37% (FCF TTM 889.3m / Revenue TTM 4.84b)
Net Margin = 25.95% (Net Income TTM 1.26b / Revenue TTM 4.84b)
Gross Margin = 76.94% ((Revenue TTM 4.84b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Tobins Q-Ratio = 22.98 (Enterprise Value 44.81b / Book Value Of Equity 1.95b)
Interest Expense / Debt = 0.86% (Interest Expense 198.8m / Debt 23.24b)
Taxrate = 21.71% (302.6m / 1.39b)
NOPAT = 1.33b (EBIT 1.69b * (1 - 21.71%))
Current Ratio = 0.32 (Total Current Assets 2.07b / Total Current Liabilities 6.49b)
Debt / Equity = 3.46 (Debt 23.24b / last Quarter total Stockholder Equity 6.72b)
Debt / EBITDA = 12.59 (Net Debt 8.97b / EBITDA 1.85b)
Debt / FCF = 26.13 (Debt 23.24b / FCF TTM 889.3m)
Total Stockholder Equity = 5.86b (last 4 quarters mean)
RoA = 5.01% (Net Income 1.26b, Total Assets 25.07b )
RoE = 21.43% (Net Income TTM 1.26b / Total Stockholder Equity 5.86b)
RoCE = 7.49% (Ebit 1.69b / (Equity 5.86b + L.T.Debt 16.76b))
RoIC = 8.77% (NOPAT 1.33b / Invested Capital 15.13b)
WACC = 4.59% (E(23.30b)/V(46.55b) * Re(8.49%)) + (D(23.24b)/V(46.55b) * Rd(0.86%) * (1-Tc(0.22)))
Shares Correlation 3-Years: 21.21 | Cagr: 0.01%
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 68.46% ; FCFE base≈588.9m ; Y1≈386.6m ; Y5≈176.8m
Fair Price DCF = 8.91 (DCF Value 3.22b / Shares Outstanding 361.7m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 9.22 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: 102.4
EPS Correlation: 24.45 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 156.9
Additional Sources for CG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle